Ma'eganedin A

ID: ALA5274207

Chembl Id: CHEMBL5274207

Max Phase: Preclinical

Molecular Formula: C37H52N4O2

Molecular Weight: 584.85

Associated Items:

Names and Identifiers

Canonical SMILES:  O[C@H]1[C@H]2[C@@H]3c4[nH]c5ccccc5c4CCN3CN3CCCC/C=C\CC[C@@]45CN(CCCC/C=C\CC[C@@]1(O)[C@H]34)CC[C@@H]25

Standard InChI:  InChI=1S/C37H52N4O2/c42-34-31-29-18-23-39-21-13-7-3-2-6-12-20-37(34,43)35-36(29,25-39)19-11-5-1-4-8-14-22-41(35)26-40-24-17-28-27-15-9-10-16-30(27)38-32(28)33(31)40/h1-2,5-6,9-10,15-16,29,31,33-35,38,42-43H,3-4,7-8,11-14,17-26H2/b5-1-,6-2-/t29-,31+,33+,34-,35+,36-,37-/m0/s1

Standard InChI Key:  VCGMNYKSEGJGRF-WDLSOWTHSA-N

Alternative Forms

  1. Parent:

    ALA5274207

    ---

Associated Targets(non-human)

L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Micrococcus luteus (7463 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacillus subtilis (32866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Corynebacterium xerosis (106 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 584.85Molecular Weight (Monoisotopic): 584.4090AlogP: 5.78#Rotatable Bonds:
Polar Surface Area: 65.97Molecular Species: BASEHBA: 5HBD: 3
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.11CX Basic pKa: 10.11CX LogP: 5.31CX LogD: 2.25
Aromatic Rings: 2Heavy Atoms: 43QED Weighted: 0.34Np Likeness Score: 1.14

References

1. Luo B, Song X..  (2021)  A comprehensive overview of β-carbolines and its derivatives as anticancer agents.,  224  [PMID:34332400] [10.1016/j.ejmech.2021.113688]
2. Dai J, Dan W, Schneider U, Wang J..  (2018)  β-Carboline alkaloid monomers and dimers: Occurrence, structural diversity, and biological activities.,  157  [PMID:30125723] [10.1016/j.ejmech.2018.08.027]

Source